Daniel J George Selected Research

Daniel J George Research Topics

Disease

104	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 09/2002
73	Neoplasms (Cancer) 10/2022 - 01/2002
68	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 01/2002
25	Disease Progression 01/2022 - 06/2005
20	Neoplasm Metastasis (Metastasis) 04/2022 - 11/2007
12	Circulating Neoplastic Cells 10/2022 - 08/2011
9	Carcinoma (Carcinomatosis) 12/2020 - 02/2002
9	Pain (Aches) 01/2017 - 03/2007
7	Kidney Neoplasms (Kidney Cancer) 01/2021 - 07/2003
4	Hypertension (High Blood Pressure) 03/2021 - 03/2016
4	Fatigue 10/2020 - 10/2008
4	Hypoxia (Hypoxemia) 01/2017 - 09/2004
3	Inflammation (Inflammations) 01/2017 - 09/2014
3	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2005
3	Neutropenia 01/2017 - 06/2006
3	Diarrhea 01/2017 - 10/2008
2	Anemia 10/2020 - 06/2006
2	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2011
2	Cancer Pain 09/2013 - 01/2013
2	Headache (Headaches) 09/2011 - 10/2008

Drug/Important Bio-Agent (IBA)

26	Sunitinib (Sutent)FDA Link 10/2021 - 01/2006
24	Biomarkers (Surrogate Marker)IBA 10/2022 - 06/2004
17	AndrogensIBA 01/2022 - 02/2002
17	Hormones (Hormone)IBA 12/2021 - 06/2004
16	enzalutamideIBA 04/2022 - 03/2015
16	Everolimus FDA Link 10/2021 - 11/2010
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 09/2002
14	Prostate-Specific Antigen (Semenogelase)IBA 12/2021 - 02/2002
14	Docetaxel (Taxotere)FDA Link 11/2019 - 01/2005
13	Abiraterone AcetateIBA 04/2022 - 01/2013
12	Prednisone (Sone)FDA LinkGeneric 12/2021 - 01/2013
11	cabozantinibIBA 09/2021 - 10/2014
10	abirateroneIBA 01/2022 - 01/2013
10	Tyrosine Kinase InhibitorsIBA 01/2021 - 09/2004
9	Radium-223IBA 01/2022 - 01/2013
9	Immune Checkpoint InhibitorsIBA 02/2021 - 01/2018
9	sipuleucel-T (APC8015)FDA Link 12/2019 - 01/2011
9	Pharmaceutical PreparationsIBA 01/2019 - 09/2002
8	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 03/2005
7	NivolumabIBA 01/2022 - 01/2018
7	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2019 - 09/2002
7	TOR Serine-Threonine KinasesIBA 08/2015 - 06/2010
6	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2008
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
5	pazopanib FDA Link 01/2021 - 09/2014
5	Sorafenib (BAY 43-9006)FDA Link 11/2015 - 03/2007
5	temsirolimus FDA Link 07/2015 - 12/2013
4	taxaneIBA 01/2022 - 06/2005
4	IpilimumabIBA 01/2022 - 01/2021
4	Testosterone (Sustanon)FDA Link 12/2021 - 01/2020
4	Biological ProductsIBA 03/2021 - 09/2004
4	RNA (Ribonucleic Acid)IBA 10/2020 - 12/2013
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 06/2010
4	Alkaline PhosphataseIBA 10/2019 - 09/2015
4	Narcotics (Narcotic Analgesics)IBA 02/2015 - 03/2007
4	Phosphotransferases (Kinase)IBA 10/2014 - 09/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2007 - 09/2002
3	Peptides (Polypeptides)IBA 10/2022 - 02/2004
3	Disulfiram (Antabuse)FDA Link 01/2022 - 10/2014
3	CopperIBA 01/2022 - 10/2014
3	ProdrugsIBA 01/2020 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 10/2019 - 09/2015
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 09/2012
3	CytokinesIBA 11/2016 - 01/2007
2	Antineoplastic Agents (Antineoplastics)IBA 10/2022 - 01/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2020
2	B7-H1 AntigenIBA 12/2021 - 10/2019
2	antiarrhythmic peptide (AAP)IBA 12/2021 - 01/2021
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2021 - 01/2020
2	relugolixIBA 11/2021 - 01/2020
2	angiokinesIBA 06/2021 - 01/2021
2	LigandsIBA 02/2021 - 03/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 03/2013
2	Interleukin-2 (IL2)IBA 01/2021 - 09/2004
2	AntigensIBA 10/2020 - 12/2016
2	pembrolizumabIBA 10/2020 - 01/2019
2	PlatinumIBA 10/2020 - 10/2007
2	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 01/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2003
2	Cell-Free Nucleic AcidsIBA 01/2020 - 11/2016
2	Messenger RNA (mRNA)IBA 01/2019 - 06/2003
2	Sirolimus (Rapamycin)FDA Link 10/2018 - 06/2010
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2017 - 12/2013
2	Opiate AlkaloidsIBA 01/2017 - 01/2013
2	Monoclonal AntibodiesIBA 12/2016 - 03/2013
2	MTOR InhibitorsIBA 11/2014 - 08/2014
2	tyrosine receptor (receptor, tyrosine)IBA 10/2014 - 09/2002
2	Analgesics (Analgesic Drugs)IBA 10/2014 - 09/2013
2	AtrasentanIBA 05/2014 - 10/2008
2	Zoledronic Acid (Zometa)FDA Link 12/2013 - 01/2013
2	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 03/2007
2	EnzymesIBA 09/2012 - 02/2004

Therapy/Procedure

74	Therapeutics 04/2022 - 09/2002
58	Castration 04/2022 - 05/2008
28	Immunotherapy 10/2022 - 02/2004
23	Drug Therapy (Chemotherapy) 04/2022 - 01/2005
7	Prostatectomy (Retropubic Prostatectomy) 12/2021 - 02/2004
6	Nephrectomy 02/2020 - 10/2007
5	Radiotherapy 12/2021 - 03/2007
4	Aftercare (After-Treatment) 01/2022 - 09/2011